Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Chemical and Drug Induced Liver Injury

Known as: Chemical and Drug Induced Liver Injury [Disease/Finding] 
A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal… Expand
National Institutes of Health

Related topics

Related topics

11 relations

Narrower (6)

Chemically-Induced Liver ToxicityDrug-Induced Liver DiseaseHalothane HepatitisHepatitis, Drug-Induced
Expand
In BloodMicrobiologicalnursing therapyprevention & control
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death worldwide. Risk factors for HCC include… Expand
  • figure 1
  • figure 2
  • figure 3
Review
2019
Review
2019
Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome
Mesenchymal stem cell (MSC)-sourced secretome, defined as the set of MSC-derived bioactive factors (soluble proteins, nucleic… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Review
2019
Review
2019
Thrombopoietin receptor agonists: ten years later
The two thrombopoietin receptor agonists (TPO-RA), eltrombopag and romiplostim, were licensed in the US for treatment of immune… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Review
2019
Review
2019
The diabetes pandemic and associated infections: suggestions for clinical microbiology
&NA; There are 425 million people with diabetes mellitus in the world. By 2045, this figure will grow to over 600 million… Expand
Review
2019
Review
2019
Assessing the human health risks of perfluorooctane sulfonate by in vivo and in vitro studies.
The wide use of perfluorooctane sulfonate (PFOS) has led to increasing concern about its human health risks over the past decade… Expand
Review
2019
Review
2019
Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges.
Chronic infection with hepatitis C virus is a major cause of liver disease and hepatocellular carcinoma worldwide. After the… Expand
Review
2019
Review
2019
Inflammatory pathways in alcoholic steatohepatitis.
Inflammatory processes are primary contributors to the development and progression of alcoholic steatohepatitis (ASH), with… Expand
Review
2019
Review
2019
The Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic Approaches
Oxidative stress and inflammation are the most important pathogenic events in the development and progression of liver diseases… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2019
Review
2019
Autophagy in liver diseases: Time for translation?
Autophagy is a self-eating catabolic pathway that contributes to liver homeostasis through its role in energy balance and in the… Expand
Review
2019
Review
2019
Serum Hepatitis B Virus RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection
Chronic hepatitis B infection is one of the major etiological causes of liver failure, cirrhosis, and hepatocellular carcinoma… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE